Skip to content

Clinical trials

Recruiting Triple Negative Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Recruiting Clear all

306 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20161
20173
20181
20197
20209
202119
202230
202339
202468
202568
202657

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting306

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University20
National Cancer Institute (NCI)6
H. Lee Moffitt Cancer Center and Research Institute5
Memorial Sloan Kettering Cancer Center5
Emory University4
Novartis Pharmaceuticals4
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University4
UNC Lineberger Comprehensive Cancer Center4
Beijing Biotech3
Bristol-Myers Squibb3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms306
Breast Neoplasms117
Carcinoma, Non-Small-Cell Lung55
Squamous Cell Carcinoma of Head and Neck33
Colorectal Neoplasms29
Ovarian Neoplasms29
Endometrial Neoplasms24
Neoplasm Metastasis22
Uterine Cervical Neoplasms21
Melanoma20

Trials

Showing 1 to 25 of 306. Each trial links to its page on Pharma Observatory.

206 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.